Jeremy M Levin Ovid Therapeutics Inc. (OVID) insider trading activity
Jeremy M Levin is CEO of Ovid Therapeutics Inc.. Currently has a direct ownership of 3.62 Million shares of OVID, which is worth approximately $3.62 Million. The most recent transaction as insider was on Mar 18, 2024, when has been sold 18,248 shares (Common Stock) at a price of $2.76 per share, resulting in proceeds of $50,364. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
3.62M
0%
3M change
0.51%
12M change
Total Value Held
$3.62 Million
JML
Jeremy M Levin
CEO
New York, NY